-
Interaction of Tim-3 and Tim-3 ligand regulates T helper type 1 responses and induction of peripheral tolerance.
Nat Immunol. 2003 Nov;4(11):1102-10
PMID: 14556006
-
Role of LAG-3 in regulatory T cells.
Immunity. 2004 Oct;21(4):503-13
PMID: 15485628
-
IL-21 and TGF-beta are required for differentiation of human T(H)17 cells.
Nature. 2008 Jul 17;454(7202):350-2
PMID: 18469800
-
CD4⁺T cells: differentiation and functions.
Clin Dev Immunol. 2012;2012:925135
PMID: 22474485
-
Tim-3 expression defines regulatory T cells in human tumors.
PLoS One. 2013;8(3):e58006
PMID: 23526963
-
The transcription factor T-bet controls regulatory T cell homeostasis and function during type 1 inflammation.
Nat Immunol. 2009 Jun;10(6):595-602
PMID: 19412181
-
IL-17 and Th17 Cells.
Annu Rev Immunol. 2009;27:485-517
PMID: 19132915
-
Premature terminal exhaustion of Friend virus-specific effector CD8+ T cells by rapid induction of multiple inhibitory receptors.
J Immunol. 2010 May 1;184(9):4696-707
PMID: 20351188
-
TIM3+FOXP3+ regulatory T cells are tissue-specific promoters of T-cell dysfunction in cancer.
Oncoimmunology. 2013 Apr 1;2(4):e23849
PMID: 23734331
-
TIM-3 is expressed on activated human CD4+ T cells and regulates Th1 and Th17 cytokines.
Eur J Immunol. 2009 Sep;39(9):2492-501
PMID: 19676072
-
Tim-3 inhibits T helper type 1-mediated auto- and alloimmune responses and promotes immunological tolerance.
Nat Immunol. 2003 Nov;4(11):1093-101
PMID: 14556005
-
Emerging Tim-3 functions in antimicrobial and tumor immunity.
Trends Immunol. 2011 Aug;32(8):345-9
PMID: 21697013
-
Anti-TIM3 antibody promotes T cell IFN-γ-mediated antitumor immunity and suppresses established tumors.
Cancer Res. 2011 May 15;71(10):3540-51
PMID: 21430066
-
Control of regulatory T cell development by the transcription factor Foxp3.
Science. 2003 Feb 14;299(5609):1057-61
PMID: 12522256
-
Regulatory T-cell suppressor program co-opts transcription factor IRF4 to control T(H)2 responses.
Nature. 2009 Mar 19;458(7236):351-6
PMID: 19182775
-
CD4+ regulatory T cells control TH17 responses in a Stat3-dependent manner.
Science. 2009 Nov 13;326(5955):986-91
PMID: 19797626
-
TIM-3 and its regulatory role in immune responses.
Curr Top Microbiol Immunol. 2011;350:1-15
PMID: 20700701
-
Immune checkpoints in central nervous system autoimmunity.
Immunol Rev. 2012 Jul;248(1):122-39
PMID: 22725958
-
Tim-3 expression on PD-1+ HCV-specific human CTLs is associated with viral persistence, and its blockade restores hepatocyte-directed in vitro cytotoxicity.
J Clin Invest. 2010 Dec;120(12):4546-57
PMID: 21084749
-
Allograft rejection is restrained by short-lived TIM-3+PD-1+Foxp3+ Tregs.
J Clin Invest. 2012 Jul;122(7):2395-404
PMID: 22684103
-
Down-regulation of interleukin-2 production by CD4(+) T cells expressing TIM-3 through suppression of NFAT dephosphorylation and AP-1 transcription.
Immunobiology. 2012 Oct;217(10):986-95
PMID: 22445722
-
Tim-3 pathway controls regulatory and effector T cell balance during hepatitis C virus infection.
J Immunol. 2012 Jul 15;189(2):755-66
PMID: 22706088
-
CTLA-4 control over Foxp3+ regulatory T cell function.
Science. 2008 Oct 10;322(5899):271-5
PMID: 18845758
-
Role of Th1 and Th17 cells in organ-specific autoimmunity.
J Autoimmun. 2008 Nov;31(3):252-6
PMID: 18502610
-
Human CD4+CD25+ regulatory T cells.
Semin Immunol. 2004 Apr;16(2):89-98
PMID: 15036232
-
Regulatory T cells inhibit dendritic cells by lymphocyte activation gene-3 engagement of MHC class II.
J Immunol. 2008 May 1;180(9):5916-26
PMID: 18424711
-
Mechanisms of impaired regulation by CD4(+)CD25(+)FOXP3(+) regulatory T cells in human autoimmune diseases.
Nat Rev Immunol. 2010 Dec;10(12):849-59
PMID: 21107346
-
TIMs: central regulators of immune responses.
J Exp Med. 2008 Nov 24;205(12):2699-701
PMID: 19015312
-
HCV-specific T cells in HCV/HIV co-infection show elevated frequencies of dual Tim-3/PD-1 expression that correlate with liver disease progression.
Eur J Immunol. 2010 Sep;40(9):2493-505
PMID: 20623550
-
Th1-specific cell surface protein Tim-3 regulates macrophage activation and severity of an autoimmune disease.
Nature. 2002 Jan 31;415(6871):536-41
PMID: 11823861
-
Characterization of HCV-specific CD4+Th17 immunity in recurrent hepatitis C-induced liver allograft fibrosis.
Am J Transplant. 2011 Apr;11(4):775-85
PMID: 21446979
-
TIM-3 expression characterizes regulatory T cells in tumor tissues and is associated with lung cancer progression.
PLoS One. 2012;7(2):e30676
PMID: 22363469
-
Targeting Tim-3 and PD-1 pathways to reverse T cell exhaustion and restore anti-tumor immunity.
J Exp Med. 2010 Sep 27;207(10):2187-94
PMID: 20819927
-
Th17 cells are increased with severity of liver inflammation in patients with chronic hepatitis C.
J Gastroenterol Hepatol. 2012 Feb;27(2):273-8
PMID: 21592230
-
The plasticity and stability of regulatory T cells.
Nat Rev Immunol. 2013 Jun;13(6):461-7
PMID: 23681097
-
CD4+FOXP3+ T regulatory cells in human autoimmunity: more than a numbers game.
J Immunol. 2011 Sep 1;187(5):2061-6
PMID: 21856944
-
Functionally distinct subsets of human FOXP3+ Treg cells that phenotypically mirror effector Th cells.
Blood. 2012 May 10;119(19):4430-40
PMID: 22438251
-
Main features of human T helper 17 cells.
Ann N Y Acad Sci. 2013 May;1284:66-70
PMID: 23651196
-
Tim-3/galectin-9 signaling pathway mediates T-cell dysfunction and predicts poor prognosis in patients with hepatitis B virus-associated hepatocellular carcinoma.
Hepatology. 2012 Oct;56(4):1342-51
PMID: 22505239
-
TIM-3: a novel regulatory molecule of alloimmune activation.
J Immunol. 2010 Nov 15;185(10):5806-19
PMID: 20956339
-
Regulatory T cells: customizing for the clinic.
Sci Transl Med. 2011 May 18;3(83):83ps19
PMID: 21593399
-
Tim-3 expression defines a novel population of dysfunctional T cells with highly elevated frequencies in progressive HIV-1 infection.
J Exp Med. 2008 Nov 24;205(12):2763-79
PMID: 19001139